Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab

OBJECTIVE: Here we report a case of a splenectomized white woman with natalizumab-associated progressive multifocal leukoencephalopathy (PML), occurring as early as after 11 infusions and provide blood fluorescence-activated cell sorting (FACS) analyses before and after natalizumab treatment. DESIGN...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, De-Hyung, Waschbisch, Anne, Lämmer, Alexandra B, Doerfler, Arnd, Schwab, Stefan, Linker, Ralf A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854515/
https://www.ncbi.nlm.nih.gov/pubmed/24107235
http://dx.doi.org/10.1186/1742-2094-10-123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854515/
https://www.ncbi.nlm.nih.gov/pubmed/24107235
http://dx.doi.org/10.1186/1742-2094-10-123

Ejemplares similares